Home

promóció egy Tornász overall survival common bile duct cancer park Esik Palást

Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer  | NEJM Evidence
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer | NEJM Evidence

Distinct prognosis of biliary tract cancer according to tumor location,  stage, and treatment: a population-based study | Scientific Reports
Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: a population-based study | Scientific Reports

Cholangiocarcinoma - Wikipedia
Cholangiocarcinoma - Wikipedia

Comparison of the recurrence-free survival rates between hilar... |  Download Scientific Diagram
Comparison of the recurrence-free survival rates between hilar... | Download Scientific Diagram

Comparison of the overall-survival rates between hilar... | Download  Scientific Diagram
Comparison of the overall-survival rates between hilar... | Download Scientific Diagram

Overall survival of patients with cholangiocarcinoma Kaplan Meier plot... |  Download Scientific Diagram
Overall survival of patients with cholangiocarcinoma Kaplan Meier plot... | Download Scientific Diagram

Cholangiocarcinoma 2020: the next horizon in mechanisms and management |  Nature Reviews Gastroenterology & Hepatology
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology

Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ®)–Health Professional  Version - NCI
Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ®)–Health Professional Version - NCI

Overall survival rates for patients with distal bile duct cancer after... |  Download Scientific Diagram
Overall survival rates for patients with distal bile duct cancer after... | Download Scientific Diagram

Cholangiocarcinoma | Nature Reviews Disease Primers
Cholangiocarcinoma | Nature Reviews Disease Primers

Survival outcomes and progonostic factors of extrahepatic  cholangiocarcinoma patients following surgical resection: Adjuvant therapy  is a favorable prognostic factor
Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor

Cholangiocarcinoma - Bile Duct Cancer - Causes, Symptoms, Treatment
Cholangiocarcinoma - Bile Duct Cancer - Causes, Symptoms, Treatment

Dual-organ invasion is associated with a lower survival rate than  single-organ invasion in distal bile duct cancer: A multicenter study |  Scientific Reports
Dual-organ invasion is associated with a lower survival rate than single-organ invasion in distal bile duct cancer: A multicenter study | Scientific Reports

The new insight of treatment in Cholangiocarcinoma
The new insight of treatment in Cholangiocarcinoma

Biliary tract cancers: NCDB role in rare malignancy | The Bulletin
Biliary tract cancers: NCDB role in rare malignancy | The Bulletin

Tumour Budding as an Independent Prognostic Factor for Survival in Patients  With Distal Bile Duct Cancer | Anticancer Research
Tumour Budding as an Independent Prognostic Factor for Survival in Patients With Distal Bile Duct Cancer | Anticancer Research

xmlinkhub
xmlinkhub

Overall survival stratified by stage group of distal bile duct... |  Download Scientific Diagram
Overall survival stratified by stage group of distal bile duct... | Download Scientific Diagram

Survival according to overall tumor stage (f stage) of hilar or... |  Download Scientific Diagram
Survival according to overall tumor stage (f stage) of hilar or... | Download Scientific Diagram

Medicines | Free Full-Text | PARP Inhibitors in Biliary Tract Cancer: A New  Kid on the Block?
Medicines | Free Full-Text | PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?

Comparison of the overall-survival rates between hilar... | Download  Scientific Diagram
Comparison of the overall-survival rates between hilar... | Download Scientific Diagram

Radiation therapy for recurrent extrahepatic bile duct cancer | PLOS ONE
Radiation therapy for recurrent extrahepatic bile duct cancer | PLOS ONE

Frontiers | The Evolving Role of Radiation Therapy in the Treatment of  Biliary Tract Cancer
Frontiers | The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer

Adding Nab-Paclitaxel to Standard Care Does Not Improve Outcomes in Biliary  Tract Cancers - Cancer Therapy Advisor
Adding Nab-Paclitaxel to Standard Care Does Not Improve Outcomes in Biliary Tract Cancers - Cancer Therapy Advisor